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Abstract
Background: Chylothorax is an uncommon disorder with respiratory, nutritional and immunological manifestations. Surgical management is
indicated in case of recurrence or failure after conservative treatment. We report our experience with video-assisted right-sided supradiaphrag-
matic thoracic duct ligation for non-traumatic, non-postoperative persistent or recurrent chylothorax. Patients and methods: The medical
records of six patients operated at our institution between 1999 and 2004 were retrospectively reviewed. A right-sided chylothorax was found in
four patients, a left-sided in one, and a bilateral in one. Three patients developed chylothorax after chemotherapy and chest irradiation for
malignant diseases (lymphoma in two patients and breast cancer in one), one in the context of lymphangioleiomyomatosis, one due to a non-
diagnosed lymphoma, and one after heart transplantation. Results: Themean operative timewas 102 min, with an average length of hospital stay
of 14 days. Persistent cessation of chylous effusion within 7 days after surgery was observed in 5/6 patients without recurrence during a mean
follow-up time of 41 months. One patient with undiagnosed mediastinal lymphoma required re-operation and thoracic duct ligation on day 8 by
right-sided thoracotomy due to persistent chylothorax. No 30-day mortality was recorded. Two patients presented postoperative complications
including respiratory insufficiency requiring mechanical ventilation in one, and chylous ascites development requiring peritoneo-venous LeVeen
shunting in one patient. Conclusions: Recurrent or persistent non-traumatic chylothorax may be successfully treated by video-assisted right
supradiaphragmatic thoracic duct ligation.
# 2006 Elsevier B.V. All rights reserved.
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Chylothorax is an uncommon but vexing clinical disorder
[1—4] and may be a life-threatening condition if left
untreated [2]. It may be related to various underlying causes
such as penetrating or blunt trauma to the neck, chest or
upper abdomen, surgery involving the oesophagus, lung,
pleura, mediastinum and heart, and diseases such as
lymphangioleiomyomatosis or lymphoma [1—6].
The clinical presentation of chylothorax is mainly related
to the presence of pleural effusion and nutritional deteriora-
tion resulting from loss of large amounts of electrolytes,
proteins, lipids and vitamins [1—4]. Immune deficiency and
lymphopenia are other significant characteristics of the
disease [1,2,4].
The optimal treatment of chylothorax is still controver-
sial and depends on the setting in which it evolves.
Conservative management is usually recommended in first* Corresponding author. Tel.: +41 21 3142408; fax: +41 21 3142358.
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medium-chain triglyceride supplemented regimens for
several weeks [1—4]. However, repeated thoracocentesis
or chest tube drainage is often required during conservative
treatment in order to relief dyspnea, which bears an
increased risk of pleural infection [1,2,4]. Refractory
chylothorax after failure of medical therapy is usually
addressed for surgery. Several surgical procedures have
been described in this context including pleurodesis,
pleurectomy, right supradiaphragmatic thoracic duct liga-
tion and pleuro-peritoneal shunting [1—4,7]. Thoracic duct
ligation has been introduced by Lampson [8] in 1948 which
decreased the mortality rate from 50% to 15%. It has been
recognised that surgical intervention to ligate the thoracic
duct should be performed before the debilitating complica-
tions of chylothorax have manifested. Although thoracic
duct ligation has been accomplished by thoracoscopy, most
surgeons rely on open procedure through a right thoracot-
omy. Thoracic duct ligation performed by a VATS approach
has not gainedwide acceptance sincemost reports deal with
anecdotal observations and are basedmainly on case reports
[5,9—21].We report our experiencewith thoracoscopic right
supra-diaphragmatic thoracic duct ligation in a small series
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traumatic chylothorax.2. Patients and methods
All patients presenting with symptomatic, recurrent or
persisting non-traumatic chylothorax who underwent
video-assisted right supradiaphragmatic thoracic duct
ligation between 1999 and 2004 at our institution were
the subject of this report. Inclusion criteria for video-
assisted supradiaphragmatic duct ligation consisted of the
presence of persisting or recurrent chylothorax with
elevated triglyceride levels > 1.3 mmol/l in the pleural
effusion following unsuccessful conservative management
and chest tube drainage. CT scan of the chest was
performed after drainage in order to confirm full expansion
of the lungs. The presence of an entrapped lung by
loculated effusions or a pleural peel was an exclusion
criteria for video-assisted supradiaphragmatic thoracic
duct ligation.Fig. 1. Video-assisted right-sided supradiaphragmatic thoracic duct ligation for non
trocarts in the mid-axillary line at the levels of the 8th and 10th intercostal space
visualisation and division of the pulmonary ligament; (c) division of the parietal pleura
vein, dissection and medial retraction of the esophagus and dissection of the ventr
between the azygous vein, the vertebral bodies, the esophagus and the aorta by th2.1.1. Surgical technique
General anaesthesia with selective double lumen
intubation was performed and the patient was placed in
a left lateral position. After exclusion of the right lung, two
7 mm thoracoports were inserted in the mid-axillary line at
the levels of 8th and 10th intercostal spaces, respectively
(Fig. 1a). The optic and a suction device were introduced
which allowed the emptying and inspection of the pleural
cavity. A 4 cm incision was then performed at the postero-
lateral level of the 9th intercostal space in order to
introduce conventional surgical instruments without thor-
acoport (Fig. 1a). The inferior border of the lung was
grasped by an endoscopic duval forceps and the pulmonary
ligament was divided (Fig. 1b). The azygous vein was
identified and the parietal pleura was incised between the
azygous vein and the vertebral bodies, from the diaphrag-
matic hiatus to the inferior pulmonary vein. The oesophagus
was dissected from the hiatus to the inferior pulmonary vein
and retracted medially (Fig. 1c). The descending aorta
was dissected behind the esophagus on its medial aspect-traumatic persistent or recurrent chylothorax; (a) positioning of two 7 mm
, and a 4 cm incision at the posterior level of the 9th intercostal space; (b)
along azygous vein and the esophagus from the hiatus to the inferior pulmonary
al part of the descending aorta; and (d) mass ligation of all fibro-fatty tissue
ree ligatures of 3-0 prolene1.
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Fig. 2. Schematic drawing of video-assisted right supradiaphragmatic thoracic
duct ligation. Mass ligation of all the fibro-fatty tissue between the oesopha-
gus, the dorsal aspect of the aorta, the azygos vein and the vertebral bodies
was performed by using three ligatures of non-resorbable 3-0 polypropylene
(prolene1) at a distance of 2 cm each, beginning at the level of the diaphragm.
Fig. 3. Postoperative chest X-ray of patient 1 who developed respiratory
insufficiency due to infiltration of the right lower lobe and chylous bronchor-
rhoe after successful video-assisted thoracic duct ligation.(Fig. 1d). Mass ligation of all the fibro-fatty tissue between
the oesophagus, the dorsal aspect of the aorta, the azygos
vein and the vertebral bodies was performed by using three
ligatures of non-resorbable 3-0 polypropylene (prolene1)
at a distance of 2 cm each, beginning at the level of the
diaphragm (Fig. 2). An endoscopic device was used for this
purpose. Chest tube drainage (28F) was performed after
removal of the thoracoports. Oral feeding without dietary
restriction was started at postoperative day 1.3. Results
The patient’s demographics and characteristics are
summarised in Table 1. A right-sided chylothorax was seen
in four patients, a left-sided in one, and a bilateral in one.Table 1
Patient’s characteristics and postoperative results after video-assisted right-sided s
Patient number Age (years) Sex Cause Side Operative time (
1 51 F RT-CHTa l + r 140
2 51 F RT-CHTb l 130
3 42 M RT-CHTc r 50
4 57 M Heart TX r 88
5 49 M LAMd r 100
6 57 F Lymphoma l 70
a Mediastinal irradiation and chemotherapy for lymphoma 20 years ago.
b Chest wall irradiation and chemotherapy for breast cancer 15 years ago.
c Chest wall irradiation and chemotherapy for breast cancer 15 years ago.
d Pulmonary lymphangioleiomyomatosis.Three patients developed a chylothorax after chemotherapy
and chest irradiation for malignant diseases (lymphoma in
two patients and breast cancer in one), one in the context of
lymphangioleiomyomatosis, one due to a non-diagnosed
lymphoma, and one after heart transplantation. The duration
of chylothorax before thoracic duct ligation ranged from 7 to
14 days.
The mean operative time was 102 min (range 50—140 min)
and the average hospitalisation time was 14 days (range 8—28
days). No perioperative complications were observed in
patients with a left-sided chylothorax treated by video-
assisted right supradiaphragmatic thoracic duct ligation. The
mean time of chest tube drainagewas 7 days ranging from 6 to
10 days. Immediate cessation of chylous fluid secretion was
observed in 5/6 patients despite the fact that the patients had
eaten normally starting at postoperative day 1, without anyupradiaphragmatic thoracic duct ligation
min) Drainage (days) Recurrence Complications
10 — Respiratory insufficiency
6 — —
6 — —
10 — —
7 — —
8 Day 8, re-operation —
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thoracotomy on day 8 postoperatively due to persistent
chylothorax. The revisited chest revealed enlarged lymph
nodes along the posterior lower mediastinum consistent with
malignant lymphoma on frozen section examination. Mass
ligations were performed using 2-0 mersilene1 sutures at
three different levels through thoracotomy, which was
followed by cessation of chylous drainage within 2 days.
There was no 90-day postoperative morbidity in 4/6 patients.
One patient (status post radiochemotherapy for mediastinal
lymphoma) developed postoperative infiltration of the right
lower lobe associated with chylous bronchorrhoe and respira-
tory insufficiency requiring tracheotomy and mechanical
ventilation without recurrent chylothorax (Fig. 3). Another
patient (status post heart transplantation) developed a
chylous ascites on postoperative day 10 without recurrent
chylothorax and treated by a Le Veen peritoneo-venous shunt.
No recurrent pleural effusion was observed in any patient
during a mean follow-up time of 41 months.4. Discussion
Non-traumatic, non-postoperative chylothorax may be
addressed for surgery in case of recurrence or persistence
despite adequate conservative management [1,2,5]. Medical
treatment of a chylothorax related to malignancies is
associated with a significant failure rate due to direct
infiltration, external compression or rupture of the thoracic
duct by the underlying disease [1,6]. The indications for a
surgical approach consist of an average daily chylous loss
exceeding 1500 ml in adults or 100 ml per year of age in
children for a 5-day period, and a continuous drainage of chyle
over a period of 14 days of conservative management
[1,2,7,22]. Timing of surgery is still a matter of debate and
various surgical procedures have been described. Supradiaph-
ragmaticmass ligation of the thoracic duct through right-sided
thoracotomy is generally considered as the modality of choice
in the absence of signs of restriction and entrapped lung by a
thickened pleural peel on chest CT [2,4,20,23]. The dis-
advantage consists of the morbidity related to thoracotomy
performed in fail and malnourished patients.
It has been demonstrated that thoracic duct ligation may
be successfully performed by using video-assisted thoraco-
scopy in order to avoid a thoracotomy, with apparently lesser
postoperative pain, shorter recovery time and hospital stay
[9—21]. However, this technique has not gained wide
acceptance at date due to the rarity of this intervention.
Only few reports relying mainly on anecdotic observations
have been published [9—21]. Various procedures have been
described for this purpose including ligation, stapling or
clipping of the thoracic duct, or fibrin glue application in
order to achieve pleurodesis [12—17]. The main advantage of
this technique is the avoidance of thoracotomy, which may
result in lesser reluctance of physicians towards a surgical
approach, quicker referral for surgery and as a consequence,
a decreased morbidity related to chylous loss.
Our results emerging from a small series of patients with
recurrent or persisting non-traumatic chylothorax undergoing
video-assisted thoracic duct ligation endorse the results of
previous reports. The procedure is safe and efficient providedthere are no restriction or entrapment of the lung by a chronic
pleural peel underlining the importance of preoperative
assessment by chest CT scan. All patients in our series
underwent right-sided supradiaphragmatic mass ligation of
the fibro-fatty tissue between azygous vein, esophagus,
descending aorta and vertebral bodies irrespective of the
side of chylothorax [22—25]. Individual dissection and ligation
of the thoracic duct bears the risk of missing anatomic
variations and duplications of the thoracic duct during surgery
which may occur in as much as 40% of the patients [25].
The majority of our patients revealed a low operation
time, duration of chest tube drainage and hospitalisation,
and no postoperative morbidity. Patients with a left-sided
chylothorax treated by a video-assisted right supradiaphrag-
matic thoracic duct ligation did equally as well as those with
a right-sided chylothorax. No recurrence was observed in 5/6
patients after a mean follow-up time of 41 months. However,
one patient with lymphoma situated in the posterior aspect
of the mediastinum revealed a persistent chylothorax after
video-assisted thoracic duct ligation with cessation after a
redo-operation through thoracotomy. One patient developed
postoperative respiratory insufficiency due to right lower
lobe infiltration and chylous bronchorrhoe, which required
prolonged mechanical ventilation and tracheostomy
although there was no residual pleural effusion after duct
ligation. This patient developed right-sided chylothorax
several years after radiochemotherapy for mediastinal
lymphoma. Another patient developed chylous ascites after
successful thoracic duct ligation for chylothorax occurring
after heart transplantation. These observations underline
the somewhat unpredictable and poorly interpretable course
after surgical interventions for non-traumatic or non-post-
operative lymphatic disorders.
Our results demonstrate that video-assisted right-sided
supradiaphragmatic thoracic duct ligation offers rewarding
long-term results for the treatment of recurrent or persistent
non-traumatic and non-operative chylothorax, irrespective
of the side of its manifestation and its underlying cause. The
main advantage of the VATS approach is its low morbidity in
already debilitated patients, which may result in better
acceptance of surgery for this disorder and earlier referral for
surgical intervention.
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